Defecation Function and Quality of Life in the Patients Treated With Surgery for Slow Transit Constipation
Launched by THIRD MILITARY MEDICAL UNIVERSITY · Mar 7, 2020
Trial Information
Current as of July 06, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective surgery is in improving bowel function and the quality of life for people who suffer from slow transit constipation (STC). STC is a condition where patients struggle to have regular bowel movements, often relying on laxatives or other treatments that may not work. The trial specifically looks at two types of surgery called total and subtotal colectomy to see how they help patients both in the short term and over a five-year period.
To participate in this trial, candidates must be between the ages of 65 and 74, have severe constipation symptoms that have not improved with other treatments for over a year, and show specific test results indicating poor bowel movement function. Participants will undergo surgery and then be monitored regularly to assess their bowel function and quality of life. This study aims to provide valuable insights into how surgery can help improve daily life for those with STC, making it an important option for patients seeking relief from their symptoms.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. The clinical manifestations all met the Roman IV standard for the diagnosis of functional constipation.
- • 2. Patients with severe constipation symptoms were unable to defecate naturally and need laxatives to assist defecation or still unable to defecate.
- • 3. Colonic transport tests showed that the opaque X-ray markers remained more than 20% after 72 hours.
- • 4. All conservative treatment for more than 1 year failed.
- • 5. Patients had a strong desire for surgery, and no other contraindications to surgery.
- Exclusion Criteria:
- • 1. Megacolon was detected with barium enema examination.
- • 2. Colonoscopy suggested the presence of intestinal organic lesions or a history of colorectal cancer treatment.
- • 3. Gastric and small intestinal transport dysfunction.
- • 4. There are depression, anxiety and other mental symptoms.
- • 5. Constipation type irritable bowel syndrome.
- • 6. History of inflammatory bowel disease.
About Third Military Medical University
Third Military Medical University is a leading medical research institution located in China, renowned for its commitment to advancing healthcare through innovative clinical research and education. With a strong emphasis on military and civilian health, the university integrates cutting-edge scientific methodologies and interdisciplinary collaboration to enhance patient outcomes. Its robust clinical trial framework supports a diverse range of studies, fostering the development of new therapeutic interventions and contributing to the global body of medical knowledge. Through rigorous ethical standards and a focus on translational research, Third Military Medical University aims to address critical health challenges and improve community health on both local and international levels.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yuzhong, Chongqing, China
Patients applied
Trial Officials
Weidong Tong, MD
Study Chair
Army Military Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials